Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The overall heterogeneity for total death was I 2 = 33.7% (95% uncertainty intervals, 0 and 60.9%) (moderate) (Additional file 1: Table S3)
I.DunbarJ.NicollJ
A small percentage of people taking bisphosphonates will experience osteonecrosis bone death in the jaw
Following discovery of a sparse number of occurrences of progressive multifocal leukoencephalopathy (PML) in those taking a FAE, median duration of FAE therapy to PML symptom onset or appearance of first PML brain lesion was 31 months (range 6110), with median duration of lymphocytopenia to PML symptoms being 23 months (range 672)
US$ 22.60
US$ 21.22
US$ 21.43
US$ 20.54
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 21.83
